RK
Rajesh Kumar Patra
About Rajesh Kumar Patra
Data last updated:
Rajesh Kumar Patra is a Director at Riocure Pharmaceuticals Private Limited (since 2019) and Director at Riozen Pharmaceutical Private Limited (since 2016). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1.35 Cr; the largest is Riocure Pharmaceuticals Private Limited at ₹1.34 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Jun 2019 | 2018 | ₹1.34 Cr (FY 2024) | Active | |
| Director | 02 Nov 2016 | 2016 | ₹47,039 (FY 2024) | Active |
Board colleagues of Rajesh Kumar Patra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sujata Pradhan Subhadarsini | 08254993 | Riocure Pharmaceuticals Private Limited | Director |
| Jagdeep Bansal | 00698149 | Riozen Pharmaceutical Private Limited | Director |
| Kuldeep Bansal | 07623242 | Riozen Pharmaceutical Private Limited | Director |
| Smita Samal | 07623048 | Riozen Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Kumar Patra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Kumar Patra
Rajesh Kumar Patra currently holds 2 directorships: Riocure Pharmaceuticals Private Limited (Director, since 28 Jun 2019, revenue ₹1.34 Cr (FY 2024)); Riozen Pharmaceutical Private Limited (Director, since 02 Nov 2016, revenue ₹47,039 (FY 2024)).
Rajesh Kumar Patra was first appointed on 02 Nov 2016 as Director at Riozen Pharmaceutical Private Limited. The most recent appointment on record is 28 Jun 2019 at Riocure Pharmaceuticals Private Limited.
The 2 current companies of Rajesh Kumar Patra that report revenue have a combined latest revenue of ₹1.35 Cr: Riocure Pharmaceuticals Private Limited ₹1.34 Cr (FY 2024); Riozen Pharmaceutical Private Limited ₹47,039 (FY 2024).
The current boards of Rajesh Kumar Patra's companies include Sujata Pradhan Subhadarsini (Riocure Pharmaceuticals Private Limited), Jagdeep Bansal (Riozen Pharmaceutical Private Limited), Kuldeep Bansal (Riozen Pharmaceutical Private Limited), Smita Samal (Riozen Pharmaceutical Private Limited).